Clinic
Jones Family Medicine Clinic PLLC
Jones Family Medicine Clinic PLLC was paid $9.41M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoJONES FAMILY MEDICINE CLINIC PLLC
LAUREL, MS 39440
LAUREL, MS 39440
33aNPI1841385168assigned 10/03/2006
33bProvider typePrimary Care Clinic/Center
28Total paid$9.41M
24GClaims641,112
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Mississippi
Rank by total paid#1 of 85
Median peer was paid$100K
This provider vs. median94×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 100,394 | $1.19M | |
| 2019 | 97,565 | $1.56M | |
| 2020 | 85,841 | $985K | |
| 2021 | 147,162 | $1.73M | |
| 2022 | 116,017 | $1.90M | |
| 2023 | 57,293 | $1.26M | |
| 2024incomplete | 36,840 | $788K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 57,667 | 47,642 | $3.52M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 40,420 | 32,056 | $1.68M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 16% | 27,324 | 21,574 | $1.52M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.9% | 25,613 | 21,739 | $651K |
| 87634 | 3.4% | 7,215 | 5,932 | $318K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.7% | 12,478 | 9,894 | $255K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 4,440 | 3,467 | $252K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 7,153 | 5,269 | $192K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 15,657 | 7,114 | $173K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 14,223 | 12,014 | $146K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 1,752 | 1,392 | $143K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.3% | 4,598 | 3,766 | $122K |
84 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 2,527 | $110K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 11,001 | $106K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 2,475 | $32K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,202 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,196 | $21K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 342 | $21K |
| 80061 | Lipid panel | <1% | 2,183 | $21K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,924 | $18K |
| 80076 | <1% | 2,621 | $15K | |
| 87807 | <1% | 1,577 | $14K | |
| 99490 | Ccm add 20min | <1% | 973 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,418 | $7K |
| 81003 | <1% | 4,978 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,080 | $6K |
| 74018 | <1% | 331 | $6K | |
| 87428 | <1% | 113 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 591 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 240 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 80 | $2K |
| 99385 | <1% | 33 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 31 | $1K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $1K |
| 90756 | <1% | 71 | $799.81 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $744.47 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 187 | $593.28 |
| 84479 | <1% | 124 | $545.08 | |
| 84436 | <1% | 111 | $502.33 | |
| 92551 | <1% | 92 | $494.15 | |
| 82043 | <1% | 134 | $332.67 | |
| 81025 | <1% | 69 | $305.07 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 21 | $272.84 |
| 96160 | <1% | 161 | $262.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 508 | $155.19 |
| 84439 | <1% | 32 | $153.34 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $142.33 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 98 | $136.59 |
| 93000 | <1% | 13 | $134.05 | |
| 99406 | <1% | 18 | $128.39 | |
| 96127 | <1% | 41 | $111.48 | |
| 99173 | <1% | 160 | $93.09 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 306 | $33.61 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $26.88 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 17 | $18.30 |
| 82607 | <1% | 18 | $15.08 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 17,818 | $6.90 |
| 3078F | 0% | 21,911 | $0.00 | |
| 3288F | 0% | 26,743 | $0.00 | |
| 1159F | 0% | 60,428 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 2,106 | $0.00 |
| 3077F | 0% | 902 | $0.00 | |
| 1160F | 0% | 55,443 | $0.00 | |
| 4004F | 0% | 257 | $0.00 | |
| 99497 | 0% | 42 | $0.00 | |
| 1100F | 0% | 947 | $0.00 | |
| G9458 | Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user | 0% | 86 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 44 | $0.00 |
| 1158F | 0% | 412 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 396 | $0.00 |
| G9624 | Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user | 0% | 21 | $0.00 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 46 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 266 | $0.00 |
| G9923 | Safety concerns screen provided and negative | 0% | 224 | $0.00 |
| 1125F | 0% | 32,365 | $0.00 | |
| 1126F | 0% | 36,636 | $0.00 | |
| 1111F | 0% | 318 | $0.00 | |
| 3074F | 0% | 25,816 | $0.00 | |
| 3072F | 0% | 15,000 | $0.00 | |
| 3079F | 0% | 11,441 | $0.00 | |
| 1101F | 0% | 42,492 | $0.00 | |
| 3075F | 0% | 6,518 | $0.00 | |
| 1170F | 0% | 475 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 3,754 | $0.00 |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 6,086 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 105 | $0.00 |
| G2181 | Bmi not documented due to medical reason or patient refusal of height or weight measurement | 0% | 206 | $0.00 |
| 3080F | 0% | 408 | $0.00 | |
| 3061F | 0% | 337 | $0.00 | |
| 3011F | 0% | 52 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 119 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 143 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 12 | $0.00 |
| 3049F | 0% | 18 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 3048F | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJONES, KAYE (BUSINESS MANAGER)